Biopolym. Cell. 2019; 35(5):371-380.
Bioorganic Chemistry
Features of antimicrobial activity of some 5-aminomethylene-2-thioxo-4-thiazolidinones
1, 2, 3Holota S. M., 4Derkach G. O., 4Zasidko V. V., 5Trokhymchuk V. V., 6Furdychko L. O., 1Demchuk I. L., 1Semenciv G. M., 3Soronovych I. I., 4Kutsyk R. V., 1, 7Lesyk R. B.
- Danylo Halytsky Lviv National Medical University
69, Pekarska Str., Lviv, Ukraine, 79010 - Lesya Ukrainka Eastern European National University
13, Volya Av, Lutsk, Ukraine, 43025 - Lviv Medical Institute
76, V. Polischuk Str., Lviv, Ukraine, 79018 - Ivano-Frankivsk National Medical Universitу
2, Halytska Str., Ivano-Frankivsk, Ukraine, 76018 - P. L. Shupik National medical academy of post-graduate education
9, Dorohozhytska Str., Kyiv, Ukraine, 04112 - Bogomolets National Medical University
13, Shevchenko Blvd., Kyiv, Ukraine, 01601 - University of Information Technology and Management in Rzeszow
2, Sucharskiego Str., Rzeszow, Poland, 35-225
Abstract
Aim. To study the antimicrobial properties of 2-thioxo-4-thiazolidinone enaminone derivatives with L-β-phenyl-α-alanine fragment in molecule. Methods. Micromethod of diffusion in agar; micromethod of serial dilutions in agar. Test-objects - clinical isolates of microorganisms: methicillin-sensitive strain of Staphylococcus aureus (MSSA), methicillin-resistant strain of Staphylococcus aureus (MRSA), methicillin-resistant strain of Staphylococcus haemolyticus (MRSH), Escherichia coli; Pseudomonas aeruginosa, ESβL + Klebsiella pneumonia, Candida albicans, Candida tropicalis. Results. Screening of antimicrobial activity of 13 new 2-thioxo-4-thiazolidinone derivatives was carried out. The methicillin-resistant strain of Staphylococcus aureus (MRSA) was the most susceptible to the tested compounds. A number of derivatives exhibit synergism in combination with amoxicillin against the strain ESβL+ Klebsiella pneumonie. The structure-antimicrobial activity relationship is analyzed in detail. Conclusions. The tested 5-R-aminomethylene derivatives of ethyl 2-(4-oxo-2-thioxothiazolidin-3-yl)-3-phenylpropionic acid exhibit the moderate antimicrobial activity against gram-positive and gram-negative bacteria, as well as against Candida fungi. The antimicrobial activity of the tested compounds depends on the structure features of the enamine fragment.
Keywords: antibacterial, antifungal activity, 4-thiazolidinones, enaminones
Full text: (PDF, in English)
References
[1]
Jackson N, Czaplewski L, Piddock LJ. Discovery and development of new antibacterial drugs: learning from experience? J Antimicrob Chemother. 2018; 73(6):1452-9.
[2]
Travis A, Chernova O, Chernov V, Aminov R. Antimicrobial drug discovery: Lessons of history and future strategies. Expert Opin Drug Discov. 2018; 13(11):983-5.
[3]
Brown ED, Wright GD. Antibacterial drug discovery in the resistance era. Nature, 2016; 529(7586):336-43.
[4]
Lee AS, de Lencastre H, Garau J, Kluytmans J, Malhotra-Kumar S, Peschel A, Harbarth S. Methicillin-resistant Staphylococcus aureus. Nat Rev Dis Primers. 2018; 4:18033.
[5]
Tommasi R, Brown DG, Walkup GK, Manchester JI, Miller AA. ESKAPEing the labyrinth of antibacterial discovery. Nat Rev Drug Discov, 2015; 14(8):529-42.
[6]
Rondevaldova J, Hummelova J, Tauchen J, Kokoska L. In vitro antistaphylococcal synergistic effect of isoflavone metabolite demethyltexasin with amoxicillin and oxacillin. Microb Drug Resist. 2018; 24(1):24-9.
[7]
Almaaytah A, Qaoud MT, Abualhaijaa A, Al-Balas Q, Alzoubi KH. Hybridization and antibiotic synergism as a tool for reducing the cytotoxicity of antimicrobial peptides. Infect Drug Resist. 2018; 11:835-47.
[8]
Payne DJ, Gwynn MN, Holmes DJ, Pompliano DL. Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat Rev Drug Discov, 2007; 6(1):29-40.
[9]
Zervosen A, Lu WP, Chen Zh, White RE, Demuth ThP, Fre're JM. Interactions between Penicillin-Binding Proteins (PBPs) and Two Novel Classes of PBP Inhibitors, Arylalkylidene Rhodanines and Arylalkylidene Iminothiazolidin-4-ones. Antimicrob Agents Chemother, 2004; 48(3):961-9.
[10]
Sim MM, Ng SB, Buss AD, Crasta ShC, Goh KL, Lee SK. Benzylidene rhodanines as novel inhibitors of UDP-N-acetylmuramate/L-alanine ligase. Bioorg Med Chem Lett, 2002; 12(4):697-9.
[11]
Orchard MG, Neuss JC, Galley CM, Carr A, Porter DW, Smith P, Scopes DI, Haydon D, Vousden K, Stubberfield CR, Young K, Page M. Rhodanine-3-acetic acid derivatives as inhibitors of fungal protein mannosyl transferase 1 (PMT1). Bioorg Med Chem Lett, 2004; 14(15):3975-8.
[12]
Grant EB, Guiadeen D, Baum EZ, Foleno BD, Jin H, Montenegro DA, Nelson EA, Bush K, Hlasta DJ. The synthesis and SAR of rhodanines as novel class C β-lactamase inhibitor. Bioorg Med Chem Lett, 2000; 10(19):2179-82.
[13]
Gualtieri M, Bastide L, Villain-Guillot P, Michaux-Charachon S, Latouche J, Leonetti JP. In vitro activity of a new antibacterial rhodanine derivative against Staphylococcus epidermidis biofilms. J Antimicrob Chemother, 2006; 58(4):778-83.
[14]
Konai MM, Ghosh C, Yarlagadda V, Samaddar S, Haldar J. Membrane active phenylalanine conjugated lipophilic norspermidine derivatives with selective antibacterial activity. J Med Chem. 2014; 57(22):9409-23.
[15]
Derkach GO, Golota SM, Zasidko VV, Soronovych II, Kutsyk RV, Lesyk RB. The synthesis and the study of antimicrobial properties of 5-R,R'-aminometylene derivatives of thiazolidine-2,4-dione and 4-thioxothiazolidine-2-one. Zh Org Farm Khim. 2016; 14(3):32-7.
[16]
Derkach GO, Golota SM, Trufin YaO, Roman OM, Sementsiv GM, Soronovych II, Kutsyk RV, Grellier P, Lesyk RB. Synthesis and biological activity of 5-aminomethylene-2-thioxothiazolidin-4-ones derivatives. Farm Oglyad. 2017; 2:5-11.
[17]
Golota S, Sydorenko I, Surma R, Karpenko O, Gzella A, Lesyk R. Facile one-pot synthesis of 5-aryl/heterylidene-2-(2-hydroxyethyl- and 3-hydroxypropylamino)-thiazol-4-ones via catalytic aminolysis. Synth Commun. 2017; 47(11):1071-6.
[18]
Holota S, Shylych Ya, Derkach H, Karpenko O, Gzella A, Lesyk R. Synthesis of 4-(2H-[1,2,4]-Triazol-5-ylsulfanyl)-1,2-dihydropyrazol-3-one via Ring-Switching Hydrazinolysis of 5-Ethoxymethylidenethiazolo[3,2-b][1,2,4]triazol-6-one. Molbank. 2018; 2018(4):M1022.
[19]
Holota S, Kryshchyshyn A, Derkach H, Trufin Y, Demchuk I, Gzella A, Grellier P, Lesyk R. Synthesis of 5-enamine-4-thiazolidinone derivatives with trypanocidal and anticancer activity. Bioorg Chem. 2019; 86:126-36.
[20]
Kaminskyy D, Kryshchyshyn A, Lesyk R. Recent developments with rhodanine as a scaffold for drug discovery. Expert Opin Drug Discov. 2017; 12(12):1233-52.
[21]
Kaminskyy D, Kryshchyshyn A, Lesyk R. 5-Ene-4-thiazolidinones - An efficient tool in medicinal chemistry. Eur J Med Chem. 2017; 140: 542-94.
[22]
Thornsberry C, McDougal LK. Successful use of broth microdilution in susceptibility tests for methicillin-resistant (heteroresistant) staphylococci. J Clin Microbiol. 1983; 18(5):1084-91
[23]
Balouiri M, Sadik M, Ibnsouda SK. Methods for in vitro evaluating antimicrobial activity: A review. J Pharm Anal. 2016; 6(2):71-9.
